Background
==========

Osteoarthritis (OA) is an age-related degenerative disease that is characterized by the degradation of joint cartilage and inflammation of the synovium \[[@b1-medscimonit-25-6051]--[@b3-medscimonit-25-6051]\]. The typical clinical signs and symptoms of OA are pain, swelling, and stiffness, usually associated with reduced activity and limitation of movement \[[@b4-medscimonit-25-6051]\]. Chronic OA results in the formation of osteophytes, and deformation and narrowing of the joint space. OA significantly reduces the quality of life for patients and can result in physical disability, which has an increasing socioeconomic and healthcare burden \[[@b5-medscimonit-25-6051],[@b6-medscimonit-25-6051]\]. Severe OA commonly results in joint replacement, particularly in elderly individuals \[[@b7-medscimonit-25-6051]\]. Currently, pharmacological treatments for OA primarily include the use of oral pain medication, including opioid analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), intra-articular injection of corticosteroids, and surgical treatment including osteotomy, arthroplasty, and arthrodesis \[[@b8-medscimonit-25-6051]--[@b10-medscimonit-25-6051]\]. However, pharmacological treatments for OA are aimed at alleviating the symptoms of the disease rather than treating the underlying causes, and have several side effects, including an increased risk of cardiovascular events and infection \[[@b11-medscimonit-25-6051],[@b12-medscimonit-25-6051]\]. Therefore, more effective and safer therapeutic approaches are required for treating patients with OA.

Traditional Chinese medicine (TCM) has been used widely for several decades for the treatment of a range of diseases and has the advantage of being inexpensive and widely available, and because many medicines are derived from natural sources such as herbs, they have fewer side effects \[[@b13-medscimonit-25-6051]\]. Several TCMs have been used to treat OA and are both effective and safe \[[@b14-medscimonit-25-6051],[@b15-medscimonit-25-6051]\]. Therefore, for the treatment of OA, it would be helpful to identify the most effective TCM compounds. Previous studies have shown that Shaoyao Gancao decoction (SGD) is effective in reducing the clinical symptoms of OA by improving joint function and movement. SGD is an effective formula that has been described in the Treatise on Febrile and Miscellaneous Diseases (Shang Han Za Bing Lun) by the third-century Chinese physician Zhang Zhognjing. SGD contains two Chinese herbal medicines, shaoyao (SY) derived from*Radix Paeoniae Alba*, and gancao (GC) derived from *Glycyrrhizae Radix et Rhizoma,* in a 1: 1 ratio \[[@b16-medscimonit-25-6051]\]. Pharmacological studies have shown that the two compounds in the SGD formulation have a synergistic effect in reducing inflammation, pain, and swelling and improving joint function in patients with OA \[[@b17-medscimonit-25-6051]\]. However, the underlying pharmacological mechanisms of action of SGD and its components in the treatment of OA remain unclear, and the pharmacodynamic properties of its components and key targets remain to be identified.

Network pharmacology is a new and powerful method that integrates chemo-informatics, bio-informatics, network biology, network analysis and traditional pharmacology \[[@b18-medscimonit-25-6051]\]. The method of network pharmacology conforms to the systemic or holistic view of TCM theory and is a novel strategy to elucidate the active compounds and potential mechanisms of TCM formulas. Therefore, this study aimed to use network pharmacology to identify the bioactive components and targets of SGD, to search for common targets for SGD in the treatment of OA, to understand the underlying mechanisms of action of the disease targets, and to mine for disease-related genes.

Material and Methods
====================

Construction of a database of the components of Shaoyao Gancao decoction (SGD)
------------------------------------------------------------------------------

[Figure 1](#f1-medscimonit-25-6051){ref-type="fig"} shows a schematic representation of the network pharmacology study of Shaoyao Gancao decoction (SGD) in the treatment of osteoarthritis (OA), including the two active components, shaoyao (SY) and gancao (GC). The data relating to the chemical compounds, SY and GC were derived from the Traditional Chinese Medicine (TCM) Databases\@Taiwan (*<http://tcm.cmu.edu.tw/>*) \[[@b19-medscimonit-25-6051]\], and the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database (*<http://lsp.nwu.edu.cn/tcmsp.php>*) \[[@b20-medscimonit-25-6051]\]. In total, 365 compounds were identified in SGD after removing the duplicate data, including 280 compounds in GC and 85 compounds in SY.

Screening of the active ingredients in SGD
------------------------------------------

The 365 potential compounds from SY and GC were filtered using two adsorption, distribution, metabolism, and excretion (ADME)-related models, integrating drug-likeness (DL) and oral bioavailability (OB). Drug-likeliness is a qualitative concept used in drug design to determine how drug-like a prospective compound is to describe and optimize pharmacokinetic and pharmaceutical properties \[[@b19-medscimonit-25-6051],[@b21-medscimonit-25-6051]\]. Oral bioavailability indicates the drug-like nature of molecules as therapeutic agents and represents the relative amount of orally administered drug that reaches the blood circulation, shown by the convergence of the ADME process \[[@b22-medscimonit-25-6051]\]. To identify the active components of SGD, the ingredients conforming to the requirements of both OB ≥30% and DL ≥0.18, based on the published literature and the information from the TCMSP database, were identified for further analysis \[[@b23-medscimonit-25-6051]\]. Also, putative targets of potential compounds in SY and GC were identified from the STITCH, ChEMBL and PubChem databases, and those without target information were excluded.

Target genes related to the identified compounds
------------------------------------------------

To identify the relevant targets of the potential compounds in SY and GC, the STITCH (*<http://stitch.embl.de/>*) \[[@b24-medscimonit-25-6051]\], ChEMBL (*<http://www.ebi.ac.uk/chembl/>*) \[[@b25-medscimonit-25-6051]\], and PubChem (*<http://pubchem.ncbi.nih.gov/>*) databases were used \[[@b26-medscimonit-25-6051]\]. A final list of genes associated with compounds, with a confidence score of \>0.7, was obtained that suggested a high confidence score according to STITCH. The ChEMBL is a manually curated database for storing standardized bioactivity, molecules, targets, and drug data, which are abstracted regularly from the primary medicinal chemistry literature \[[@b27-medscimonit-25-6051]\]. The PubChem database is a resource for biological activities of small molecules, including substance information, compound structure, and bioactivity, and the data are experimentally validated. All the active ingredients identified in the present study were entered into the STITCH, ChEMBL and PubChem databases with the *Homo sapiens* species setting. The gene information, including the name, gene ID, and organism, was confirmed using the UniProt protein sequence resource (*<https://www.uniprot.org>*) \[[@b28-medscimonit-25-6051]\]. After removing duplicates, the detailed information of targets obtained is described in [Supplementary Table 1](#s1-medscimonit-25-6051){ref-type="supplementary-material"}.

Related targets of osteoarthritis (OA)
--------------------------------------

Information on OA-associated target genes was collected from the following resources. DrugBank (*<https://www.drugbank.ca/>*) \[[@b29-medscimonit-25-6051]\] is a comprehensive online database that provides extensive biochemical and pharmacological information on drugs and their mechanisms of action and targets, and 78 genes related to OA were identified from this database. GeneCards (*<http://www.genecards.org/>*) is a comprehensive database incorporating information on all annotated and predicted genes \[[@b30-medscimonit-25-6051]\], which was searched using the keyword "osteoarthritis," which identified 46 genes. The Online Mendelian Inheritance in Man^®^ (OMIM) database (*<http://www.omim.org/>*) \[[@b31-medscimonit-25-6051]\] is a comprehensive research resource of human genes and genetic phenotypes, from which 65 genes associated with OA were selected. There were 187 targets linked with OA after deleting redundant targets, and the information regarding these targets is provided in [Supplementary Table 2](#s2-medscimonit-25-6051){ref-type="supplementary-material"}.

Construction of the pharmacological networks
--------------------------------------------

Network construction was established using four main steps. First, a compound-compound target network was established by linking compounds and predicted targets with a degree of \>3. Second, a protein-protein interaction (PPI) network of compounds and targets was developed by linking the compound targets and predicted targets of other human proteins. Third, a PPI network of OA targets was constructed by linking the known OA-related targets and predicted targets of other human proteins. Fourth, a PPI network of targets for SGD and OA was developed by intersecting the PPI network of compounds and the PPI network of OA targets. The graphical and diagrammatic visualized networks were constructed using Cytoscape version 3.7.0 (*<http://www.cytoscape.org/>*) \[[@b32-medscimonit-25-6051]\], which is a software package for visualizing network analysis.

Cluster analysis
----------------

Cluster analysis is a classification method that involves interconnected regions showing the inherent laws in the network \[[@b13-medscimonit-25-6051]\]. The Molecular Complex Detection (MCODE) plug-in was used to detect densely connected regions and cluster analysis in the PPI network \[[@b33-medscimonit-25-6051]\]. In this study, we selected significant cluster modules from the constructed PPI network using MCODE. The criteria settings were set as follows: node score cutoff=0.2; K-core=2; and degree of cutoff=2.

Gene Ontology (GO) and pathway enrichment analysis
--------------------------------------------------

The Gene Ontology (GO) database (*<http://geneontology.org/>*), including biological process, cell component, and molecular function terms, was used to identify the possible biological mechanisms using high-throughput genome or transcriptome data \[[@b34-medscimonit-25-6051]\]. The Kyoto Encyclopedia of Genes and Genomes (KEGG) database (*<https://www.kegg.jp/>*) is a knowledge database for identifying the systematic functions and biological relevance of candidate targets \[[@b35-medscimonit-25-6051]\]. In this study, GO functional annotation and KEGG pathway analysis were performed using Bioconductor clusterProfiler, an R package used for enrichment analysis of gene clusters \[[@b36-medscimonit-25-6051]\].

Results
=======

Screening for the active compounds of Shaoyao Gancao decoction (SGN) involved in osteoarthritis (OA)
----------------------------------------------------------------------------------------------------

From the two active components of Shaoyao Gancao decoction (SGD), shaoyao (SY) and gancao (GC), 365 compounds were obtained from the Traditional Chinese Medicine Systems Pharmacology(TCMSP) database and the traditional Chinese medicine (TCM) Databases\@Taiwan, with 280 compounds from GC and 85 from SY. The values of oral bioavailability (OB) and drug-likeness (DL) (OB ≥30% and DL ≥0.18) were used to screen potential active compounds from GC and SY, and a total 23 active compounds met the screening standards. The properties of the compounds are shown in [Table 1](#t1-medscimonit-25-6051){ref-type="table"}.

Target screening of SGD in the treatment of osteoarthritis
----------------------------------------------------------

In the present study, the STITCH, ChEMBL, and PubChem databases were used to screen 226 targets corresponding to the active ingredients in SGD, with 188 targets for SY, 146 targets for GC, and 108 for SY and GC. These gene targets included cellular tumor antigen p53 (TP53), chlorotoxin derivative (CA4), estrogen receptor beta (ESR2), and multidrug resistance protein 1 (ABCB1), which are involved in inflammation \[[@b37-medscimonit-25-6051]\], cell proliferation \[[@b38-medscimonit-25-6051]\], and angiogenesis \[[@b39-medscimonit-25-6051]\]. DrugBank, GeneCards, and the Online Mendelian Inheritance in Man^®^ (OMIM) databases were also used to screen 187 targets associated with OA, removing compounds with duplication targets ([Supplementary Table 3](#s3-medscimonit-25-6051){ref-type="supplementary-material"}). The obtained compounds and targets were used to construct the pharmacology network.

Compound-compound network targets
---------------------------------

A compound-compound target network was developed to identify the relationship between the compounds of SGD and their candidate targets ([Figure 2](#f2-medscimonit-25-6051){ref-type="fig"}). The compound-compound target network consisted of 101 nodes (23 compounds and 78 compound targets) and 338 edges (degree \>3). The average degree of 14.69 per compound in such a network was based on the network analysis, demonstrating the multitarget treatment characteristics of SGD. In this network, the values of the degree for quercetin (degree=63) and kaempferol (degree=54) were considerably higher than that of the other components, suggesting that two chemicals probably were served as significant therapeutic compounds in OA.

Protein-protein interaction (PPI) network targets
-------------------------------------------------

The PPI networks of compound targets were developed to identify the interactions between SGD-related proteins and other relative proteins with 448 nodes (45 compound targets, 26 OA targets, 19 compound/OA targets, and other relevant proteins) and 1,869 edges ([Figure 3](#f3-medscimonit-25-6051){ref-type="fig"}) were constructed to determine the interactive effects of compounds modulated by SGD. About 19 intersection targets between compound targets and OA-related targets were identified in this network including, multidrug resistance protein 1 (ABCB1), multidrug resistance-associated protein 1(ABCC1), carbonic anhydrase 2, C-C motif chemokine 2, cytochrome P450 1A1 (CYP1A1), cytochrome P450 1A2 (CYP1A2), cytochrome P450 2C19, cytochrome P450 2C9 (CYP2C9), cytochrome P450 2D6 (CYP2D6), cytochrome P450 3A4 (CYP3A4), estrogen receptor (ER), estrogen receptor beta (ESR2), peroxisome proliferator-activated receptor alpha, peroxisome proliferator-activated receptor gamma, prostaglandin G/H synthase 2 (PTGS2), solute carrier organic anion transporter family member 1B1, TP53, UDP-glucuronosyltransferase 1--3 (UGT1A3), and UDP-glucuronosyltransferase 1--8.

PPI network of OA targets
-------------------------

The PPI network of OA targets was developed to identify the relationship between the OA-related targets and other proteins, with 394 nodes (123 OA targets and 271 other proteins that interacted with OA targets) and 2,184 edges ([Figure 4](#f4-medscimonit-25-6051){ref-type="fig"}). Considering the median values for degree (10), betweenness centrality (81.71), and closeness centrality (104.63), 27 highly connected nodes with degree \>20, betweenness centrality \>81.71, and closeness centrality \>104.63 were identified as significant OA-related targets. These targets included collagen alpha-2(V) chain, collagen alpha-1(XII) chain, cytochrome P450 3A5 (CYP3A5), CYP2C9, collagen alpha-1(XI) chain, collagen alpha-1(VI) chain, collagen alpha-1 (III) chain, collagen alpha-1(I) chain, collagen alpha-1(IX) chain, CYP1A2, collagen alpha-1(II) chain, nuclear receptor coactivator 1 (NCOA1), collagen alpha-1(X) chain, nuclear factor NF-kappa-B p105 subunit, UDP-glucuronosyltransferase 1-1 (UGT1A1), vascular endothelial growth factor A, C-C motif chemokine 5, CYP3A4, collagen alpha-2 (I) chain, IL-8, thrombospondin-1, plasminogen activator inhibitor 1, parathyroid hormone, plasminogen, transforming growth factor beta-1 proprotein, IL-6, and transcription factor AP-1 (JUN).

PPI network of targets for SGD in OA
------------------------------------

To further identify the functional mechanisms of SGD in OA, the PPI network of targets for SGD in the treatment of OA was established by intersecting the two networks described above ([Figure 5](#f5-medscimonit-25-6051){ref-type="fig"}). The network was composed of 161 nodes (21 compound targets, 17 OA targets, 27 compound/OA targets, and 96 other proteins) and 546 edges ([Figure 5](#f5-medscimonit-25-6051){ref-type="fig"}). Based on the median values for degree, betweenness centrality, and closeness centrality, which were 6, 9.93, and 44.68, respectively, nodes with the degree, betweenness centrality, and closeness centrality values that were higher than the corresponding median values (degree \>20, betweenness centrality \>81.71, and closeness centrality \>104.63) were considered as significant targets. The identified nodes included CYP3A4, nuclear receptor corepressor 1, TP53, JUN, CYP2C9, UGT1A1, CYP1A1, CYP1A2, NCOA1, nuclear receptor coactivator 2, UGT1A3, CYP3A5, CYP2D6, peroxisome proliferator-activated receptor gamma coactivator 1-alpha, IL-6, and tyrosine-protein kinase JAK2.

Cluster analysis
----------------

The PPI network of targets for SGD in OA was analyzed by using Molecular Complex Detection (MCODE), and five modules were obtained ([Figure 6A](#f6-medscimonit-25-6051){ref-type="fig"}). The biological processes, molecular functions, and signaling pathways enriched by the targets in the cluster modules were used to clarify the integral regulation of SGD for the treatment of OA ([Figure 6B, 6C](#f6-medscimonit-25-6051){ref-type="fig"}). In Gene Ontology (GO) terms, we discovered that (i) fatty acid binding, hormone receptor binding, and microtubules; (ii) regulation of lipid metabolism, hormone receptor binding, and nuclear chromatin; (iii) protein phosphatase activator activity, adenylate cyclase binding, and negative regulation of ryanodine-sensitive calcium-release channel activity; (iv) chemokine receptor activity, C-C chemokine receptor activity, and caveola; and (v) X chromosome, cyclin-dependent protein kinase holoenzyme complex, and cyclin-dependent protein serine, were enriched in clusters, supporting the role of SGD in the treatment of OA. The KEGG enrichment analysis showed that the signaling pathways were enriched in different modules ([Figure 6C](#f6-medscimonit-25-6051){ref-type="fig"}) \[[@b40-medscimonit-25-6051]\]. Module 1 was highly associated with drug metabolism, including cytochrome P450; Module 2 was highly associated with the 5′AMP-activated protein kinase (AMPK) signaling pathway; Module 3 was related to gastric acid secretion; Module 4 was associated with the tumor necrosis factor (TNF) signaling pathway and chemokine signaling pathway; Module 5 was associated with the p53 signaling pathway.

Discussion
==========

Osteoarthritis (OA) is a common form of chronic arthritis that is associated with painful symptoms that affect the quality of life for patients \[[@b41-medscimonit-25-6051],[@b42-medscimonit-25-6051]\]. Currently, the therapeutic strategies for OA are mainly symptomatic and do not treat the underlying causes. Herbal traditional Chinese medicines (TCMs) contain several compounds that will have multiple targets, pathways, and modes of action but have been shown to treat the in OA \[[@b43-medscimonit-25-6051]\]. Although Shaoyao Gancao decoction (SGD) has been used for centuries as an effective TCM for OA, its pharmacological mechanisms of action have been unclear. In this study, a network pharmacology approach was applied to determine the underlying mechanisms of SGD in OA.

After screening SGD for oral bioavailability (OB) (≥30%) and drug-likeness (DL) (≥0.18), 23 bioactive compounds were retrieved, including quercetin (OB=46.43; DL=0.28) and kaempferol (OB=41.88; DL=0.24) as potential bioactive compounds. Quercetin, one of the most abundant bioflavonoids, is known for its anti-oxidative \[[@b44-medscimonit-25-6051]\], anti-inflammatory \[[@b45-medscimonit-25-6051]\], antimicrobial \[[@b46-medscimonit-25-6051]\], and antiviral activities \[[@b47-medscimonit-25-6051]\] and its active role in promoting apoptosis in arthritic fibroblast-like synoviocytes and in protecting chondrocytes against oxidative stress \[[@b48-medscimonit-25-6051]\]. Qiu et al. showed that quercetin reduced the symptoms of OA by reducing the level of reactive oxygen species (ROS), reversing mitochondrial dysfunction, and maintaining the integrity of the extracellular matrix (ECM) of the joint cartilage \[[@b49-medscimonit-25-6051]\]. Kaempferol, a dietary element and an important bioflavonoid in vegetables and fruits \[[@b50-medscimonit-25-6051]\], has a variety of pharmacological effects and acts as an anti-oxidant, anti-inflammatory, anti-apoptotic, anti-estrogenic, and neuroprotective agent \[[@b51-medscimonit-25-6051]\]. Studies have shown that kaempferol significantly reduced in IL-1β-stimulated pro-inflammatory mediators in rat OA chondrocytes by inhibiting the NF-κB pathway \[[@b52-medscimonit-25-6051]\]. Paeoniflorin (OB=53.87; DL=0.79) plays an important role in immune regulation \[[@b53-medscimonit-25-6051]\], and hepatic protection \[[@b54-medscimonit-25-6051]\]. Several studies have reported that liquirtin (OB=65.69; DL=0.74) has multiple pharmacological effects, as an immunomodulating agent, with anti-inflammatory, anti-allergic, anti-oxidant, and antiviral properties \[[@b55-medscimonit-25-6051]\].

The PPI network of candidate targets for SGD in the treatment of OA was established based on the component and OA target networks with 161 overlapping genes. Using the median values for the degree of betweenness centrality and closeness of centrality (degree \>20, betweenness centrality \>81.71, and closeness centrality \>104.63), 16 targets were regarded as significant. It was apparent that most of these targets, including CYP3A4, CYP2C9, CYP1A1, CYP1A2, CYP3A5, and CYP2D6 in the cytochrome P450 family, were strongly associated with drug metabolism. For instance, CYP2D6 is involved in the metabolism of the dual opioid agonist and norepinephrine-serotonin re-uptake during OA therapy \[[@b56-medscimonit-25-6051]\]. CYP2C9 is involved in the metabolism of several nonsteroidal anti-inflammatory drugs (NSAIDs), contributing to the wide variability in pharmacokinetics in the metabolism of drugs \[[@b56-medscimonit-25-6051],[@b57-medscimonit-25-6051]\]. Some targets, such as TP53 and JAK2, are associated with cell growth. TP53 is associated with OA, and the SIRT1/TP53 signaling pathway modulates the pathogenesis of OA \[[@b58-medscimonit-25-6051]\]. JAK2 has a role not only in mediating angiotensin-2-induced ARHGEF1 phosphorylation \[[@b59-medscimonit-25-6051]\], but also cell in the cycle by phosphorylating CNKN1B \[[@b60-medscimonit-25-6051]\]. Previous studies have shown that the TCM, danshen, reduces cartilage damage in OA by regulating the JAK2/STAT3 and the AKT signaling pathways \[[@b61-medscimonit-25-6051]\]. Also, JAK2 is a direct target of miR-216a-5p, and long non-coding RNA (lncRNA) DANCR regulates the proliferation, inflammation, and apoptosis of chondrocytes in OA via the miR-216a-5p-JAK2-STAT3 axis \[[@b62-medscimonit-25-6051]\]. Xiong et al. found that leptin levels significantly increased in the synovial fluid of patients with OA of the temporomandibular joint (TMJ), stimulating IL-6 expression mainly via the JAK2/STAT3, p38 MAPK, and PI3K/Akt pathways \[[@b63-medscimonit-25-6051]\]. Previous studies have shown that lncRNA gastric cancer-associated transcript 3 affects cell proliferation in OA by the IL-6/STAT3 signaling pathway \[[@b64-medscimonit-25-6051]\].

Because clustering modules can demonstrate the biological mechanisms of key targets in disease, we classified the PPI network into five clusters ([Figure 6A](#f6-medscimonit-25-6051){ref-type="fig"}), and performed the Gene Ontology (GO) analysis ([Figure 6B](#f6-medscimonit-25-6051){ref-type="fig"}) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis ([Figure 6C](#f6-medscimonit-25-6051){ref-type="fig"}). Based on the GO terms, it may be proposed that the pharmacological effects of SGD in OA occurred by simultaneously activating these biological processes, cell components, and molecular functions. For example, Zhang et al. found that in a mouse model, pharmaceutical inhibition of the fatty acid binding pathway reduced the symptoms of OA induced by a high-fat diet \[[@b65-medscimonit-25-6051]\]. Also, lipid metabolism is a chemical reaction involving lipids, which are compounds soluble in organic solvents \[[@b66-medscimonit-25-6051]\]. Park et al. showed that the functional integrity of ABCD2 in modulating lipid metabolism was through the dysregulation of miR-141, and through ACSL4 in OA \[[@b67-medscimonit-25-6051]\].

From the findings of the present study, based on the KEGG terms, the potential targets for SGD in the treatment of OA were associated with the 5′AMP-activated protein kinase (AMPK) signaling pathway, the tumor necrosis factor (TNF) signaling pathway, and the p53 signaling pathway. In the AMPK signaling pathway, AMPK serves as an intracellular sensor that not only regulates protein synthesis related to inflammation but also modulates the energy balance within chondrocytes \[[@b68-medscimonit-25-6051]\]. Previous studies have shown that several bioactive compounds protect against cartilage degeneration in an OA model via the AMPK signaling pathway, including increased mitochondrial biogenesis and reduced mitochondrial dysfunction \[[@b69-medscimonit-25-6051],[@b70-medscimonit-25-6051]\]. Zhou et al. showed that AMPK activity in chondrocytes was involved in joint homeostasis and that OA developed by promoting chondrocyte apoptosis and enhancing catabolic activity \[[@b71-medscimonit-25-6051]\]. As for the TNF signaling pathway, it includes apoptosis, cell survival, inflammation, and immune function \[[@b72-medscimonit-25-6051]\]. The TNF signaling pathway is important in protecting against the effects of OA, and the correlation between TNF-α levels and the degree of OA has previously been shown \[[@b73-medscimonit-25-6051],[@b74-medscimonit-25-6051]\]. Also, the p53 signaling pathway is involved in coordinating cellular responses to different types of stress and in promoting tumor progression. Yan et al. showed that microRNA-34a had a role in chondrocyte apoptosis and proliferation by modulating the SIRT1/p53 signaling pathway in OA \[[@b58-medscimonit-25-6051]\]. However, we found that pharmacological studies on the mechanisms and targets of the effects of SGD in the treatment of OA were previously limited. Based on the findings from the present study, future studies should be undertaken to assess the relationship between agents used in TCM, including SGD in OA, and their effects in terms of specific targets at the molecular level to validate the results based on data analysis.

Conclusions
===========

This study aimed to undertake a network pharmacology analysis of the mechanism of the effects of the traditional Chinese medicine (TCM), Shaoyao Gancao decoction (SGD), in osteoarthritis (OA). The findings showed that SGD exerted its pharmacological effects in OA by modulating multiple pathways, including the cell cycle, cell apoptosis, drug metabolism, inflammation, and immune modulation. This study also provided a theoretical basis to determine the synergistic effects of TCM in treating diseases and the role of systematic network pharmacology in elucidating the potential mechanisms of action of TCMs. However, as this study was based on data mining and data analysis, further clinical validation studies should be undertaken on the role of SGD in OA.
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GSD-associated target genes.

  Gene symbol   Herb
  ------------- --------
  ABCC2         GC
  APOB          GC
  ATAD5         GC
  BAZ2B         GC
  BDNF          GC
  BRCA1         GC
  CALM1         GC
  CBR1          GC
  CBR3          GC
  CBX1          GC
  CCL2          GC
  GFER          GC
  GSK3A         GC
  HMOX1         GC
  HSPA5         GC
  LDLR          GC
  MAPK8         GC
  MAPK9         GC
  MAZF          GC
  MBNL1         GC
  MLLT3         GC
  MMP9          GC
  NOS2          GC
  PDE5A         GC
  PLA2G7        GC
  PPME1         GC
  RAPGEF1       GC
  RAPGEF3       GC
  SHBG          GC
  SLC5A1        GC
  SLC5A2        GC
  SLCO2B1       GC
  SMAD3         GC
  SMPD1         GC
  TIM23         GC
  UGT1A1        GC
  UGT1A10       GC
  UGT2B15       GC
  ABCB11        SY
  ABCG5         SY
  ABCG8         SY
  ADAM10        SY
  ADAM17        SY
  ALB           SY
  ALPI          SY
  ALPL          SY
  APOBEC3F      SY
  APOBEC3G      SY
  APOE          SY
  ARSA          SY
  BIRC5         SY
  BLM           SY
  CAT           SY
  CDK1          SY
  CFTR          SY
  CHRM1         SY
  CISD1         SY
  CTDSP1        SY
  CTSD          SY
  CYCS          SY
  CYP2A7        SY
  CYP7A1        SY
  DHCR24        SY
  DNMT1         SY
  DRD2          SY
  EHMT2         SY
  GAA           SY
  GLI1          SY
  GLI3          SY
  GLS           SY
  GPBAR1        SY
  GPT           SY
  HSD11B2       SY
  HSF1          SY
  HSP90AA1      SY
  HSP90AB1      SY
  ICAM1         SY
  IL8           SY
  KCNA5         SY
  KCNH2         SY
  KCNMA1        SY
  LMNB1         SY
  NOS3          SY
  NPSR1         SY
  NQO1          SY
  NR1H2         SY
  NR1H3         SY
  NR1I2         SY
  NR1I3         SY
  PIM2          SY
  PLCG1         SY
  PLCG2         SY
  PMP22         SY
  PRKAA2        SY
  PRKCB         SY
  PRKCE         SY
  PTPRS         SY
  PYGM          SY
  RACGAP1       SY
  RARA          SY
  RECQL         SY
  RORC          SY
  RPS6KA3       SY
  SAE1          SY
  SOD1          SY
  SP1           SY
  SREBF1        SY
  SREBF2        SY
  STK16         SY
  STK33         SY
  SYK           SY
  TLR4          SY
  UBA2          SY
  UBE2I         SY
  UGT1A7        SY
  UGT1A9        SY
  UGT3A1        SY
  XIAP          SY
  ABCB1         GC, SY
  ABCC1         GC, SY
  ABCG2         GC, SY
  ACHE          GC, SY
  AHR           GC, SY
  AKR1B1        GC, SY
  AKR1B10       GC, SY
  AKT1          GC, SY
  ALDH1A1       GC, SY
  ALOX15        GC, SY
  ALOX15B       GC, SY
  ALOX5         GC, SY
  AMY1A         GC, SY
  APEX1         GC, SY
  APP           GC, SY
  AR            GC, SY
  ATXN2         GC, SY
  BACE1         GC, SY
  BCHE          GC, SY
  CA1           GC, SY
  CA12          GC, SY
  CA2           GC, SY
  CA4           GC, SY
  CA7           GC, SY
  CASP3         GC, SY
  CDK6          GC, SY
  CLK1          GC, SY
  CYP19A1       GC, SY
  CYP1A1        GC, SY
  CYP1A2        GC, SY
  CYP1B1        GC, SY
  CYP2C19       GC, SY
  CYP2C9        GC, SY
  CYP2D6        GC, SY
  CYP3A4        GC, SY
  DAPK1         GC, SY
  DPP4          GC, SY
  DYRK1A        GC, SY
  EGFR          GC, SY
  ESR1          GC, SY
  ESR2          GC, SY
  ESRRA         GC, SY
  F2            GC, SY
  FEN1          GC, SY
  FLT3          GC, SY
  GBA           GC, SY
  GLO1          GC, SY
  GLP1R         GC, SY
  GMNN          GC, SY
  GSK3B         GC, SY
  HDAC9         GC, SY
  HIF1A         GC, SY
  HPGD          GC, SY
  HSD17B1       GC, SY
  HSD17B10      GC, SY
  HSD17B2       GC, SY
  IDH1          GC, SY
  KDM4A         GC, SY
  KDM4E         GC, SY
  LMNA          GC, SY
  MAPT          GC, SY
  MDM2          GC, SY
  MDM4          GC, SY
  MPG           GC, SY
  NEU2          GC, SY
  NFE2L2        GC, SY
  NFKB1         GC, SY
  NFKB2         GC, SY
  NOX4          GC, SY
  NR1H4         GC, SY
  NR3C1         GC, SY
  OPRD1         GC, SY
  OPRK1         GC, SY
  OPRM1         GC, SY
  PAFAH1B3      GC, SY
  PIM1          GC, SY
  PIP4K2A       GC, SY
  PNLIP         GC, SY
  POLB          GC, SY
  POLH          GC, SY
  POLI          GC, SY
  POLK          GC, SY
  PON1          GC, SY
  PPARA         GC, SY
  PPARD         GC, SY
  PPARG         GC, SY
  PREP          GC, SY
  PTGS1         GC, SY
  PTGS2         GC, SY
  PTH1R         GC, SY
  PTPN1         GC, SY
  RAPGEF4       GC, SY
  RELA          GC, SY
  RGS4          GC, SY
  RXRA          GC, SY
  SIAE          GC, SY
  SLCO1B1       GC, SY
  SLCO1B3       GC, SY
  SMN1          GC, SY
  TDP1          GC, SY
  TOP2A         GC, SY
  TP53          GC, SY
  TYR           GC, SY
  UGT1A3        GC, SY
  UGT1A4        GC, SY
  UGT1A8        GC, SY
  USP1          GC, SY
  XDH           GC, SY

###### 

Osteoarthritis-associated target genes.

  UniProt ID   Gene symbol   Description                                                                          Organism         Source
  ------------ ------------- ------------------------------------------------------------------------------------ ---------------- ---------------------
  P43026       GDF5          Growth/differentiation factor 5                                                      *Homo sapiens*   OMIM
  P02458       COL2A1        Collagen, type II, alpha-1                                                           *Homo sapiens*   OMIM
  P16112       ACAN          Aggrecan                                                                             *Homo sapiens*   OMIM
  Q9BXN1       ASPN          Asporin                                                                              *Homo sapiens*   OMIM
  P84022       SMAD3         Mothers against decapentaplegic, drosophila, homolog OF, 3                           *Homo sapiens*   OMIM
  P0DI81       TRAPPC2       Tracking protein particle complex, subunit 2                                         *Homo sapiens*   OMIM
  Q92765       FRZB          Frizzled-related protein                                                             *Homo sapiens*   OMIM
  P20849       COL9A1        Collagen, type IX, alpha-1                                                           *Homo sapiens*   OMIM
  Q99814       EPAS1         Endothelial pas domain protein 1                                                     *Homo sapiens*   OMIM
  P49747       COMP          Cartilage oligomeric matrix protein                                                  *Homo sapiens*   OMIM
  Q9UNA0       ADAMTS5       A disintegrin-like and metalloproteinase with thrombospondin type 1 Motif, 5         *Homo sapiens*   OMIM
  O15232       MATN3         Matrilin 3                                                                           *Homo sapiens*   OMIM
  Q14623       IHH           Indian Hedgehog                                                                      *Homo sapiens*   OMIM
  Q9NRR1       CYTL1         Cytokine-like protein 1                                                              *Homo sapiens*   OMIM
  P49190       PTH2R         Parathyroid hormone 2 receptor                                                       *Homo sapiens*   OMIM
  Q92731       ESR2          Estrogen receptor 2                                                                  *Homo sapiens*   OMIM
  P41159       LEP           Leptin                                                                               *Homo sapiens*   OMIM
  P0DP23       CALM1         Calmodulin 1                                                                         *Homo sapiens*   OMIM
  P41180       CASR          Calcium-sensing receptor                                                             *Homo sapiens*   OMIM
  P98066       TNFAIP6       Tumor necrosis factor-apha-induced protein 6                                         *Homo sapiens*   OMIM
  Q92743       HTRA1         HTRA serine peptidase 1                                                              *Homo sapiens*   OMIM
  P13942       COL11A2       Collagen, type XI, alpha-2                                                           *Homo sapiens*   OMIM
  Q9UHF7       TRPS1         Trichorhinophalangeal syndrome, type I                                               *Homo sapiens*   OMIM
  P11473       VDR           Vitamin D receptor                                                                   *Homo sapiens*   OMIM
  Q92633       LPAR1         Lysophosphatidic acid receptor 1                                                     *Homo sapiens*   OMIM
  P30044       PRDX5         Peroxiredoxin 5                                                                      *Homo sapiens*   OMIM
  Q9HCJ1       ANKH          ANK, mouse, Homolog OF                                                               *Homo sapiens*   OMIM
  Q9Y2L9       LRCH1         Leucine-rich repeats and calponin homology domain-containing 1                       *Homo sapiens*   OMIM
  P98160       HSPG2         Heparan sulfate proteoglycan of basement membrane                                    *Homo sapiens*   OMIM
  P56199       ITGA1         Integrin, alpha-1                                                                    *Homo sapiens*   OMIM
  P45452       MMP13         Matrix metalloproteinase 13                                                          *Homo sapiens*   OMIM
  P02452       COL1A1        Collagen, type I, alpha-1                                                            *Homo sapiens*   OMIM
  P03372       ESR1          Estrogen receptor 1                                                                  *Homo sapiens*   OMIM
  P13500       CCL2          Chemokine, CC Motif, ligand 2                                                        *Homo sapiens*   OMIM
  Q16552       IL17A         Interleukin 17A                                                                      *Homo sapiens*   OMIM
  P78536       ADAM17        A disintegrin and metalloproteinase domain 17                                        *Homo sapiens*   OMIM
  P51884       LUM           Lumican                                                                              *Homo sapiens*   OMIM
  P48061       CXCL12        Chemokine, CXC Motif, ligand 12                                                      *Homo sapiens*   OMIM
  P43235       CTSK          Cathepsin K                                                                          *Homo sapiens*   OMIM
  P11712       CYP2C9        Cytochrome P450, subfamily Iic, polypeptide 9                                        *Homo sapiens*   OMIM
  Q99969       RARRES2       Retinoic acid receptor responder 2                                                   *Homo sapiens*   OMIM
  Q9NS15       LTBP3         Latent transforming growth factor-beta-binding protein 3                             *Homo sapiens*   OMIM
  Q9HCN6       GP6           Glycoprotein VI, platelet                                                            *Homo sapiens*   OMIM
  P24001       IL32          Interleukin 32                                                                       *Homo sapiens*   OMIM
  Q92954       PRG4          Proteoglycan 4                                                                       *Homo sapiens*   OMIM
  O94907       DKK1          DICKKOPF, Xenopus, Homolog OF, 1                                                     *Homo sapiens*   OMIM
  Q9H5V8       CDCP1         CUB domain-containing protein 1                                                      *Homo sapiens*   OMIM
  Q9Y2U5       MAP3K2        Mitogen-activated protein kinase kinase kinase 2                                     *Homo sapiens*   OMIM
  Q8TCG1       CIP2A         Cell proliferation-regulating inhibitor of protein phosphatase 2A                    *Homo sapiens*   OMIM
  P14784       IL2RB         Interleukin 2 receptor, beta                                                         *Homo sapiens*   OMIM
  P17931       LGALS3        Lectin, galactoside-binding, soluble, 3                                              *Homo sapiens*   OMIM
  Q14050       COL9A3        Collagen, Type IX, alpha-3                                                           *Homo sapiens*   OMIM
  P02751       FN1           Fibronectin 1                                                                        *Homo sapiens*   OMIM
  P30203       CD6           CD6 antigen                                                                          *Homo sapiens*   OMIM
  Q96S44       TP53          Tumor protein P53                                                                    *Homo sapiens*   OMIM
  P31785       IL2RG         Interleukin 2 receptor, gamma                                                        *Homo sapiens*   OMIM
  P55287       CDH11         Cadherin 11                                                                          *Homo sapiens*   OMIM
  Q8WVB3       HEXDC         Hexosaminidase (glycosyl hydrolase family 20, catalytic domain)-containing protein   *Homo sapiens*   OMIM
  O75711       SCRG1         Stimulator of chondrogenesis 1                                                       *Homo sapiens*   OMIM
  P35354       PTGS2         Prostaglandin-endoperoxide synthase 2                                                *Homo sapiens*   OMIM
  Q12794       HYAL1         Hyaluronoglu-cosaminidase 1                                                          *Homo sapiens*   OMIM
  Q8IUL8       CILP2         Cartilage intermediate layer protein 2                                               *Homo sapiens*   OMIM
  Q8WVQ1       CANT1         Calcium-activated nucleotidase 1                                                     *Homo sapiens*   OMIM
  Q03692       COL10A1       Collagen, Type X, alpha-1                                                            *Homo sapiens*   OMIM
  P10600       TGFB3         Transforming growth factor, beta-3                                                   *Homo sapiens*   OMIM
  O15530       PDPK1         3-phosphoinositide-dependent protein kinase 1                                        *Homo sapiens*   Drugbank
  P52209       PGD           6-phosphogluconate dehydrogenase, decarboxylating                                    *Homo sapiens*   Drugbank
  Q9Y215       COLQ          Acetylcholinesterase                                                                 *Homo sapiens*   Drugbank
  P78348       ASIC1         Acid-sensing ion channel 1                                                           *Homo sapiens*   Drugbank
  O60218       AKR1B10       Aldo-keto reductase family 1 member B10                                              *Homo sapiens*   Drugbank
  P42330       AKR1C3        Aldo-keto reductase family 1 member C3                                               *Homo sapiens*   Drugbank
  P10275       AR            Androgen receptor                                                                    *Homo sapiens*   Drugbank
  Q07817       BCL2L1        Apoptosis regulator Bcl-2                                                            *Homo sapiens*   Drugbank
  P09917       ALOX5         Arachidonate 5-lipoxygenase                                                          *Homo sapiens*   Drugbank
  Q2M3GO       ABCB5         ATP-binding cassette sub-family B member 5                                           *Homo sapiens*   Drugbank
  Q96J66       ABCC11        ATP-binding cassette sub-family C member 11                                          *Homo sapiens*   Drugbank
  Q9UNQ0       ABCG2         ATP-binding cassette sub-family G member 2                                           *Homo sapiens*   Drugbank
  Q92887       ABCC2         Canalicular multispecific organic anion transporter 1                                *Homo sapiens*   Drugbank
  O15438       ABCC3         Canalicular multispecific organic anion transporter 2                                *Homo sapiens*   Drugbank
  P00918       CA2           Carbonic anhydrase 2                                                                 *Homo sapiens*   Drugbank
  P07451       CA3           Carbonic anhydrase 3                                                                 *Homo sapiens*   Drugbank
  P06276       BCHE          Cholinesterase                                                                       *Homo sapiens*   Drugbank
  P08185       SERPINA6      Corticosteroid-binding globulin                                                      *Homo sapiens*   Drugbank
  P25024       CXCR1         C-X-C chemokine receptor type 1                                                      *Homo sapiens*   Drugbank
  P13569       CFTR          Cystic fibrosis transmembrane conductance regulator                                  *Homo sapiens*   Drugbank
  P04798       CYP1A1        Cytochrome P450 1A1                                                                  *Homo sapiens*   Drugbank
  P05177       CYP1A2        Cytochrome P450 1A2                                                                  *Homo sapiens*   Drugbank
  P11509       CYP2A6        Cytochrome P450 2A6                                                                  *Homo sapiens*   Drugbank
  P20813       CYP2B6        Cytochrome P450 2B6                                                                  *Homo sapiens*   Drugbank
  P33260       CYP2C18       Cytochrome P450 2C18                                                                 *Homo sapiens*   Drugbank
  P33261       CYP2C19       Cytochrome P450 2C19                                                                 *Homo sapiens*   Drugbank
  P10632       CYP2C8        Cytochrome P450 2C8                                                                  *Homo sapiens*   Drugbank
  P10635       CYP2D6        Cytochrome P450 2D6                                                                  *Homo sapiens*   Drugbank
  P05182       CYP2E1        Cytochrome P450 2E1                                                                  *Homo sapiens*   Drugbank
  P08684       CYP3A4        PCytochrome P450 3A4                                                                 *Homo sapiens*   Drugbank
  P20815       CYP3A5        Cytochrome P450 3A5                                                                  *Homo sapiens*   Drugbank
  P02693       FABP2         Fatty acid-binding protein, intestinal                                               *Homo sapiens*   Drugbank
  P04150       NR3C1         Glucocorticoid receptor                                                              *Homo sapiens*   Drugbank
  P25021       HRH2          Histamine H2 receptor                                                                *Homo sapiens*   Drugbank
  Q04760       GLO1          Lactoylglutathione lyase                                                             *Homo sapiens*   Drugbank
  P23141       CES1          Liver carboxylesterase 1                                                             *Homo sapiens*   Drugbank
  P27361       MAPK3         Mitogen-activated protein kinase 3                                                   *Homo sapiens*   Drugbank
  P08183       ABCB1         Multidrug resistance protein 1                                                       *Homo sapiens*   Drugbank
  P33527       ABCC1         Multidrug resistance-associated protein 1                                            *Homo sapiens*   Drugbank
  O15439       ABCC4         Multidrug resistance-associated protein 4                                            *Homo sapiens*   Drugbank
  O95255       ABCC6         Multidrug resistance-associated protein 6                                            *Homo sapiens*   Drugbank
  P05164       MPO           Myeloperoxidase                                                                      *Homo sapiens*   Drugbank
  Q07869       PPARA         Peroxisome proliferator-activated receptor alpha                                     *Homo sapiens*   Drugbank
  Q03181       PPARD         Peroxisome proliferator-activated receptor delta                                     *Homo sapiens*   Drugbank
  P37231       PPARG         Peroxisome proliferator-activated receptor gamma                                     *Homo sapiens*   Drugbank
  P14555       PLA2G2A       Phospholipase A2, membrane associated                                                *Homo sapiens*   Drugbank
  O43526       KCNQ2         Potassium voltage-gated channel subfamily KQT member 2                               *Homo sapiens*   Drugbank
  O43525       KCNQ3         Potassium voltage-gated channel subfamily KQT member 3                               *Homo sapiens*   Drugbank
  Q9Y5Y4       PTGDR2        Prostaglandin D2 receptor 2                                                          *Homo sapiens*   Drugbank
  P34995       PTGER1        Prostaglandin E2 receptor EP1 subtype                                                *Homo sapiens*   Drugbank
  Q8VDQ1       PTGR2         Prostaglandin reductase 2                                                            *Homo sapiens*   Drugbank
  P19793       RXRA          Retinoic acid receptor RXR-alpha                                                     *Homo sapiens*   Drugbank
  Q9Y5Y9       SCN10A        Sodium channel protein type 10 subunit alpha                                         *Homo sapiens*   Drugbank
  P35499       SCN4A         Sodium channel protein type 4 subunit alpha                                          *Homo sapiens*   Drugbank
  Q14973       SLC10A1       Sodium/bile acid cotransporter                                                       *Homo sapiens*   Drugbank
  P46059       SLC15A1       Solute carrier family 15 member 1                                                    *Homo sapiens*   Drugbank
  Q9NSA0       SLC22A11      Solute carrier family 22 member 11                                                   *Homo sapiens*   Drugbank
  O15244       SLC22A2       Solute carrier family 22 member 2                                                    *Homo sapiens*   Drugbank
  Q8VC69       SLC22A6       Solute carrier family 22 member 6                                                    *Homo sapiens*   Drugbank
  Q9Y694       SLC22A7       Solute carrier family 22 member 7                                                    *Homo sapiens*   Drugbank
  Q8TCC7       SLC22A8       Solute carrier family 22 member 8                                                    *Homo sapiens*   Drugbank
  P46721       SLCO1A2       Solute carrier organic anion transporter family member 1A2                           *Homo sapiens*   Drugbank
  Q9Y6L6       SLCO1B1       Solute carrier organic anion transporter family member 1B1                           *Homo sapiens*   Drugbank
  Q9NYB5       SLCO1C1       Solute carrier organic anion transporter family member 1C1                           *Homo sapiens*   Drugbank
  O94956       SLCO2B1       Solute carrier organic anion transporter family member 2B1                           *Homo sapiens*   Drugbank
  P07204       THBD          Thrombomodulin                                                                       *Homo sapiens*   Drugbank
  P00750       PLAT          Tissue-type plasminogen activator                                                    *Homo sapiens*   Drugbank
  P02766       TTR           Transthyretin                                                                        *Homo sapiens*   Drugbank
  P48775       TDO2          Tryptophan 2,3-dioxygenase                                                           *Homo sapiens*   Drugbank
  P22309       UGT1A1        UDP-glucuronosyltransferase 1-1                                                      *Homo sapiens*   Drugbank
  Q9HAW8       UGT1A10       UDP-glucuronosyltransferase 1-10                                                     *Homo sapiens*   Drugbank
  P35503       UGT1A3        UDP-glucuronosyltransferase 1-3                                                      *Homo sapiens*   Drugbank
  Q9HAW9       UGT1A8        UDP-glucuronosyltransferase 1-8                                                      *Homo sapiens*   Drugbank
  O60656       UGT1A9        UDP-glucuronosyltransferase 1-9                                                      *Homo sapiens*   Drugbank
  P06133       UGT2B4        UDP-glucuronosyltransferase 2B4                                                      *Homo sapiens*   Drugbank
  P16662       UGT2B7        UDP-glucuronosyltransferase 2B7                                                      *Homo sapiens*   Drugbank
  P02768       ALB           Serum albumin                                                                        *Homo sapiens*   Drugbank, Genecards
  P23219       PTGS1         Prostaglandin G/H synthase 1                                                         *Homo sapiens*   Drugbank, Genecards
  P01584       IL1B          Interleukin 1 Beta                                                                   *Homo sapiens*   Genecards
  P08123       COL1A2        Collagen Type I Alpha 2 Chain                                                        *Homo sapiens*   Genecards
  P08254       MMP3          Matrix Metallopeptidase 3                                                            *Homo sapiens*   Genecards
  P01375       TNF           Tumor Necrosis Factor                                                                *Homo sapiens*   Genecards
  P08887       IL6           Interleukin 6                                                                        *Homo sapiens*   Genecards
  P03956       MMP1          Matrix Metallopeptidase 1                                                            *Homo sapiens*   Genecards
  P01137       TGFB1         Transforming Growth Factor Beta 1                                                    *Homo sapiens*   Genecards
  O75339       CILP          Cartilage Intermediate Layer Protein                                                 *Homo sapiens*   Genecards
  Q9NUQ7       UFSP2         UFM1 Specific Peptidase 2                                                            *Homo sapiens*   Genecards
  Q14055       COL9A2        Collagen Type IX Alpha 2 Chain                                                       *Homo sapiens*   Genecards
  O14788       TNFSF11       TNF Superfamily Member 11                                                            *Homo sapiens*   Genecards
  P10145       CXCL8         C-X-C Motif Chemokine Ligand 8                                                       *Homo sapiens*   Genecards
  O00300       TNFRSF11B     TNF Receptor Superfamily Member 11b                                                  *Homo sapiens*   Genecards
  P01033       TIMP1         TIMP Metallopeptidase Inhibitor 1                                                    *Homo sapiens*   Genecards
  O75173       ADAMTS4       ADAM Metallopeptidase With Thrombospondin Type 1 Motif 4                             *Homo sapiens*   Genecards
  P50443       SLC26A2       Solute Carrier Family 26 Member 2                                                    *Homo sapiens*   Genecards
  Q16832       DDR2          Discoidin Domain Receptor Tyrosine Kinase 2                                          *Homo sapiens*   Genecards
  Q9HBA0       TRPV4         Transient Receptor Potential Cation Channel Subfamily V Member 4                     *Homo sapiens*   Genecards
  P02741       CRP           C-Reactive Protein                                                                   *Homo sapiens*   Genecards
  P22301       IL10          Interleukin 10                                                                       *Homo sapiens*   Genecards
  P36222       CHI3L1        Chitinase 3 Like 1                                                                   *Homo sapiens*   Genecards
  O15068       MCF2L         MCF.2 Cell Line Derived Transforming Sequence Like                                   *Homo sapiens*   Genecards
  P12107       COL11A1       Collagen Type XI Alpha 1 Chain                                                       *Homo sapiens*   Genecards
  Q14807       KIF22         Kinesin Family Member 22                                                             *Homo sapiens*   Genecards
  P22003       BMP5          Bone Morphogenetic Protein 5                                                         *Homo sapiens*   Genecards
  P48436       SOX9          SRY-Box 9                                                                            *Homo sapiens*   Genecards
  P18510       IL1RN         Interleukin 1 Receptor Antagonist                                                    *Homo sapiens*   Genecards
  P02461       COL3A1        Collagen Type III Alpha 1 Chain                                                      *Homo sapiens*   Genecards
  P21941       MATN1         Matrilin 1, Cartilage Matrix Protein                                                 *Homo sapiens*   Genecards
  Q8WXS8       ADAMTS14      ADAM Metallopeptidase With Thrombospondin Type 1 Motif 14                            *Homo sapiens*   Genecards
  P22607       FGFR3         Fibroblast Growth Factor Receptor 3                                                  *Homo sapiens*   Genecards
  P51798       CLCN7         Chloride Voltage-Gated Channel 7                                                     *Homo sapiens*   Genecards
  P35555       FBN1          Fibrillin 1                                                                          *Homo sapiens*   Genecards
  P10912       GHR           Growth Hormone Receptor                                                              *Homo sapiens*   Genecards
  P02818       BGLAP         Bone Gamma-Carboxyglutamate Protein                                                  *Homo sapiens*   Genecards
  P63092       GNAS          GNAS Complex Locus                                                                   *Homo sapiens*   Genecards
  Q16394       EXT1          Exostosin Glycosyltransferase 1                                                      *Homo sapiens*   Genecards
  P01583       IL1A          Interleukin 1 Alpha                                                                  *Homo sapiens*   Genecards
  Q86Y38       XYLT1         Xylosyltransferase 1                                                                 *Homo sapiens*   Genecards
  P208908      COL5A1        Collagen Type V Alpha 1 Chain                                                        *Homo sapiens*   Genecards
  Q9GIY3       HLA-DRB1      Major Histocompatibility Complex, Class II, DR Beta 1                                *Homo sapiens*   Genecards
  Q9Y2R2       PTPN22        Protein Tyrosine Phosphatase, Non-Receptor Type 22                                   *Homo sapiens*   Genecards
  O15266       SHOX          Short Stature Homeobox                                                               *Homo sapiens*   Genecards
  Q93099       HGD           Homogentisate 1,2-Dioxygenase                                                        *Homo sapiens*   Genecards

###### 

SGD compound targets.

  Gene symbol   Herb
  ------------- --------
  ABCC2         GC
  APOB          GC
  ATAD5         GC
  BAZ2B         GC
  BDNF          GC
  BRCA1         GC
  CALM1         GC
  CBR1          GC
  CBR3          GC
  CBX1          GC
  CCL2          GC
  GFER          GC
  GSK3A         GC
  HMOX1         GC
  HSPA5         GC
  LDLR          GC
  MAPK8         GC
  MAPK9         GC
  MAZF          GC
  MBNL1         GC
  MLLT3         GC
  MMP9          GC
  NOS2          GC
  PDE5A         GC
  PLA2G7        GC
  PPME1         GC
  RAPGEF1       GC
  RAPGEF3       GC
  SHBG          GC
  SLC5A1        GC
  SLC5A2        GC
  SLCO2B1       GC
  SMAD3         GC
  SMPD1         GC
  TIM23         GC
  UGT1A1        GC
  UGT1A10       GC
  UGT2B15       GC
  ABCB11        SY
  ABCG5         SY
  ABCG8         SY
  ADAM10        SY
  ADAM17        SY
  ALB           SY
  ALPI          SY
  ALPL          SY
  APOBEC3F      SY
  APOBEC3G      SY
  APOE          SY
  ARSA          SY
  BIRC5         SY
  BLM           SY
  CAT           SY
  CDK1          SY
  CFTR          SY
  CHRM1         SY
  CISD1         SY
  CTDSP1        SY
  CTSD          SY
  CYCS          SY
  CYP2A7        SY
  CYP7A1        SY
  DHCR24        SY
  DNMT1         SY
  DRD2          SY
  EHMT2         SY
  GAA           SY
  GLI1          SY
  GLI3          SY
  GLS           SY
  GPBAR1        SY
  GPT           SY
  HSD11B2       SY
  HSF1          SY
  HSP90AA1      SY
  HSP90AB1      SY
  ICAM1         SY
  IL8           SY
  KCNA5         SY
  KCNH2         SY
  KCNMA1        SY
  LMNB1         SY
  NOS3          SY
  NPSR1         SY
  NQO1          SY
  NR1H2         SY
  NR1H3         SY
  NR1I2         SY
  NR1I3         SY
  PIM2          SY
  PLCG1         SY
  PLCG2         SY
  PMP22         SY
  PRKAA2        SY
  PRKCB         SY
  PRKCE         SY
  PTPRS         SY
  PYGM          SY
  RACGAP1       SY
  RARA          SY
  RECQL         SY
  RORC          SY
  RPS6KA3       SY
  SAE1          SY
  SOD1          SY
  SP1           SY
  SREBF1        SY
  SREBF2        SY
  STK16         SY
  STK33         SY
  SYK           SY
  TLR4          SY
  UBA2          SY
  UBE2I         SY
  UGT1A7        SY
  UGT1A9        SY
  UGT3A1        SY
  XIAP          SY
  ABCB1         GC, SY
  ABCC1         GC, SY
  ABCG2         GC, SY
  ACHE          GC, SY
  AHR           GC, SY
  AKR1B1        GC, SY
  AKR1B10       GC, SY
  AKT1          GC, SY
  ALDH1A1       GC, SY
  ALOX15        GC, SY
  ALOX15B       GC, SY
  ALOX5         GC, SY
  AMY1A         GC, SY
  APEX1         GC, SY
  APP           GC, SY
  AR            GC, SY
  ATXN2         GC, SY
  BACE1         GC, SY
  BCHE          GC, SY
  CA1           GC, SY
  CA12          GC, SY
  CA2           GC, SY
  CA4           GC, SY
  CA7           GC, SY
  CASP3         GC, SY
  CDK6          GC, SY
  CLK1          GC, SY
  CYP19A1       GC, SY
  CYP1A1        GC, SY
  CYP1A2        GC, SY
  CYP1B1        GC, SY
  CYP2C19       GC, SY
  CYP2C9        GC, SY
  CYP2D6        GC, SY
  CYP3A4        GC, SY
  DAPK1         GC, SY
  DPP4          GC, SY
  DYRK1A        GC, SY
  EGFR          GC, SY
  ESR1          GC, SY
  ESR2          GC, SY
  ESRRA         GC, SY
  F2            GC, SY
  FEN1          GC, SY
  FLT3          GC, SY
  GBA           GC, SY
  GLO1          GC, SY
  GLP1R         GC, SY
  GMNN          GC, SY
  GSK3B         GC, SY
  HDAC9         GC, SY
  HIF1A         GC, SY
  HPGD          GC, SY
  HSD17B1       GC, SY
  HSD17B10      GC, SY
  HSD17B2       GC, SY
  IDH1          GC, SY
  KDM4A         GC, SY
  KDM4E         GC, SY
  LMNA          GC, SY
  MAPT          GC, SY
  MDM2          GC, SY
  MDM4          GC, SY
  MPG           GC, SY
  NEU2          GC, SY
  NFE2L2        GC, SY
  NFKB1         GC, SY
  NFKB2         GC, SY
  NOX4          GC, SY
  NR1H4         GC, SY
  NR3C1         GC, SY
  OPRD1         GC, SY
  OPRK1         GC, SY
  OPRM1         GC, SY
  PAFAH1B3      GC, SY
  PIM1          GC, SY
  PIP4K2A       GC, SY
  PNLIP         GC, SY
  POLB          GC, SY
  POLH          GC, SY
  POLI          GC, SY
  POLK          GC, SY
  PON1          GC, SY
  PPARA         GC, SY
  PPARD         GC, SY
  PPARG         GC, SY
  PREP          GC, SY
  PTGS1         GC, SY
  PTGS2         GC, SY
  PTH1R         GC, SY
  PTPN1         GC, SY
  RAPGEF4       GC, SY
  RELA          GC, SY
  RGS4          GC, SY
  RXRA          GC, SY
  SIAE          GC, SY
  SLCO1B1       GC, SY
  SLCO1B3       GC, SY
  SMN1          GC, SY
  TDP1          GC, SY
  TOP2A         GC, SY
  TP53          GC, SY
  TYR           GC, SY
  UGT1A3        GC, SY
  UGT1A4        GC, SY
  UGT1A8        GC, SY
  USP1          GC, SY
  XDH           GC, SY
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ABCB1

:   multidrug resistance protein 1

ADME

:   adsorption, distribution, metabolism, and excretion

BP

:   biological processes

CC

:   cellular components

CM

:   Chinese Medicine

CYP1A1

:   cytochrome P450 1A1

CYP1A2

:   cytochrome P450 1A2

CYP2C9

:   cytochrome P450 2C9

CYP2D6

:   cytochrome P450 2D6

CYP3A4

:   cytochrome P450 3A4

CYP3A5

:   cytochrome P450 3A5

DL

:   drug-likeness

ESR2

:   estrogen receptor beta

GC

:   Gancao

GO

:   Gene Ontology

IL

:   interleukin

KEGG

:   Kyoto Encyclopedia of Genes and Genomes

lncRNA

:   long non-coding RNA

MCODE

:   Molecular Complex Detection

NCOA1

:   nuclear receptor coactivator 1

NSAID

:   nonsteroidal anti-inflammatory drug

OA

:   osteoarthritis

OB

:   oral bioavailability

PTGS2

:   prostaglandin G/H synthase 2

PPI

:   protein-protein interaction

SGD

:   Shaoyao-Gancao decoction

SY

:   shaoyao

TCM

:   Traditional Chinese medicine

TCMSP

:   Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform

TNF

:   tumor necrosis factor

TP53

:   cellular tumor antigen p53

UGT1A1

:   UDP-glucuronosyltransferase 1-1

UGT1A3

:   UDP-glucuronosyltranserase 1--3.

![Schematic representation of network pharmacology study of Shaoyao Gancao decoction (SGD) in the treatment of osteoarthritis (OA). SGD -- Shaoyao Gancao decoction; OA -- osteoarthritis.](medscimonit-25-6051-g001){#f1-medscimonit-25-6051}

![The compound-compound target network of Shaoyao Gancao decoction (SGD) in the treatment of osteoarthritis (OA). Blue represents the compound targets, green represents the compounds of Shaoyao Gancao decoction (SGD), and red hexagons represent the central compounds of SGD.](medscimonit-25-6051-g002){#f2-medscimonit-25-6051}

![The protein-protein interaction (PPI) network of compound targets of Shaoyao Gancao decoction (SGD) in the treatment of osteoarthritis (OA). Incarnadine (crimson) represent other proteins, purple represent compound targets, yellow represent osteoarthritis (OA) targets, and green represent compound/OA targets).](medscimonit-25-6051-g003){#f3-medscimonit-25-6051}

![The protein-protein interaction (PPI) network of osteoarthritis (OA) targets. Green ovals represent osteoarthritis (OA) targets and purple ovals represent other human proteins that interacted with OA targets.](medscimonit-25-6051-g004){#f4-medscimonit-25-6051}

![The protein-protein interaction (PPI) network of targets for Shaoyao Gancao decoction (SGD) in osteoarthritis (OA). Yellow ovals represent osteoarthritis (OA) targets, incarnadine (crimson) ovals represent compound targets, green ovals represent compound/OA targets, and blue ovals represent other human proteins that interacted with OA targets or compound targets.](medscimonit-25-6051-g005){#f5-medscimonit-25-6051}

![Enrichment analysis of the targets for Shaoyao Gancao decoction (SGD) in osteoarthritis (OA). (**A**) Clusters of the merged protein-protein interaction (PPI) network. Yellow ovals represent osteoarthritis (OA) targets, incarnadine (crimson) ovals represent compound targets, green ovals represent compound/OA targets, and blue ovals represent other human proteins that interacted with OA targets or compound targets. (**B**) The Gene Ontology (GO) pathway enrichment analysis of each cluster. (**C**) The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of each cluster.](medscimonit-25-6051-g006){#f6-medscimonit-25-6051}

###### 

The active ingredients of the two components of Shaoyao Gancao decoction (SGD), shaoyao (SY) and gancao (GC).

  Molecule ID   Molecule name                  Structure   OB      DL     Herb
  ------------- ------------------------------ ----------- ------- ------ ------
  MOL000359     Sitosterol                                 36.91   0.75   SY
  MOL000358     beta-Sitosterol                            36.91   0.75   SY
  MOL000422     Kaempferol                                 41.88   0.24   SY
  MOL001924     Paeoniflorin                               53.87   0.79   SY
  MOL000492     (+)-Catechin                               54.83   0.24   SY
  MOL000211     Mairin                                     55.38   0.78   BS
  MOL001792     Liquiritigenin                             32.76   0.18   GC
  MOL000500     Vestitol                                   74.66   0.21   GC
  MOL004328     Naringenin                                 59.29   0.21   GC
  MOL000392     Formononetin                               69.67   0.21   GC
  MOL000417     Calycosin                                  47.75   0.24   GC
  MOL004991     7-Acetoxy-2-methylisoflavone               83.71   0.27   GC
  MOL000098     Quercetin                                  46.43   0.28   GC
  MOL000354     Isorhamnetin                               49.6    0.31   GC
  MOL004910     Glabranin                                  52.9    0.31   GC
  MOL002565     Medicarpin                                 49.22   0.34   GC
  MOL004949     Isolicoflavonol                            45.17   0.42   GC
  MOL004908     Glabridin                                  53.25   0.47   GC
  MOL001484     Inermine                                   75.18   0.54   GC
  MOL004827     Semilicoisoflavone B                       48.78   0.55   GC
  MOL004959     1-Methoxyphaseollidin                      69.98   0.64   GC
  MOL004903     Liquiritin                                 65.69   0.74   GC
  MOL004948     Isoglycyrol                                44.7    0.84   GC
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